Aurobindo Pharma's share price is trading higher on December 18 despite the recent news of receiving two observations from the United States Food and Drug Administration (USFDA).At 09:22 am, Aurobindo Pharma was quoting at Rs 1,218.95, up Rs 5.50, or 0.45 percent, on the BSE.These observations came after an inspection of the Unit-V API manufacturing facility at Apitoria Pharma, a wholly owned subs...

Let's catch up on the latest news from the stock market. From significant investments to major deals, order wins, and acquisitions, here’s a quick look at which stocks will be in focus in today's trade:Stocks To WatchAurobindo PharmaThe United States Food and Drug Administration (US FDA) inspected Unit-V, an API manufacturing facility, of Apitoria Pharma, a wholly owned subsidiary of the company...

Jefferies On PI IndustriesBuy Call, Target Cut To `4,865/Sh From `5,100/ShFactored In Lower Kumiai Agchem Rev Growth Guidance While Guiding For Lower Growth In Q2Co Sees No Impact On Margin With Raw Material Prices SofteningNew Products Should Drive Growth In FY26Cut FY26/27 Revenues 3%/5% Leading To 4%/5% Cut To FY26/27 EPSProject 10% EPS CAGR Over FY24-27Jefferies On Max Financial ServicesBuy Ca...

Let's catch up on the latest news from the stock market. From significant investments to major deals, order wins, and acquisitions, here’s a quick look at which stocks will be in focus in today's trade:Quarterly EarningsZinka Logistics Solutions-BlackBuck Q2 (Consolidated YoY)Loss widens to Rs 308.4 crore Vs loss of Rs 39.7 croreRevenue surges 55.9% to Rs 987.7 crore Vs Rs 633.7 croreExceptional...

Aurobindo Pharma shares up nearly 2% on USFDA approval for nasal spray, The share touched a 52-week high of Rs 1,177 on January 30, 2024, and a 52-week low of Rs 466 on March 21, 2023.Aurobindo Pharma's share price rose nearly 2 percent in the early trade on March 20 after the company received US Food & Drug Administration (USFDA) approval for nasal spray.At 9.18 am, Aurobindo Pharma was quoting a...